NEW YORK CITY TECH

New York City Biotech

Researchers Mapped Retinal Channel Binding Site

Researchers Mapped Retinal Channel Binding Site

The study offers a new target for drug development to treat retinal degeneration by stabilizing ion channel activity.

Live Poll

Do you trust that new discoveries in molecular biology will lead to effective treatments for blindness?


Recent news

New York City Biotech